Trial Profile

A Phase I Study of Methoxyamine and Temozolomide in Patients With Advanced Solid Tumours

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Jun 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methoxyamine hydrochloride (Primary) ; Temozolomide
Indications Adenocarcinoma; Colorectal cancer; Head and neck cancer; Lung cancer; Neuroendocrine tumours; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours; Squamous cell cancer
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

17 Jun 2020 Results published in the Investigational New Drugs.
28 Feb 2019 According to a Tracon Pharmaceuticals media release, presentation of expanded cohort data by the National Cancer Institute from this trial in patients with colorectal, lung and ovarian cancer at the AACR annual meeting in Philadelphia is expected in April 2019.
26 Jul 2017 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com